View more articles

Sino Biological

SARS-CoV-2 Detection Antigens and Antibodies

To support the studies on the development of rapid diagnostic tools, vaccines and therapeutic antibodies for COVID-19, Sino Biological has developed a comprehensive panel of research reagents for the Novel Coronavirus SARS-CoV-2, including Recombinant Antigens (N protein, S protein, S1 and S2 subunits of S protein, and RBD domain of S protein), Monoclonal Antibodies, and Antigen Detection Kits.

Click for more information


Cambridge Healthtech Institute Training Seminars offer real-life case studies, problems encountered and solutions applied, and extensive coverage of the basic science and business issues underlying each topic.

April 15-16, 2020

Introduction to Small Molecule Drug Metabolism and Applications
John C.L. Erve, PhD, DABT, President, Jerve Scientific Consulting, Inc.